Article
Prognostic Impact of Concurrent DNMT3A, FLT3 and NPM1 Gene Mutations in Acute Myeloid Leukemia Patients.
Clinical lymphoma, myeloma & leukemia - 1 Dec 2021
Elrhman Heba Allah E Abd, El-Meligui Yomna M, Elalawi Saffaa M
Abstract excerpt
BACKGROUND: Acute myeloid leukemia (AML) is one of the rapidly progressing malignancies which is characterized by unregulated proliferation of hematopoietic precursors. Technological improvements enhanced the availability of genetic AML biomarkers. The clinical relevance of these molecular markers for AML diagnosis, planning of therapy and risk stratification are increasing evidently. METHODS: In current study,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
